Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/12/2003WO2003006612A3 Production of transduced hematopoietic progenitor cells
09/12/2003WO2003001877A3 Methods for the diagnosis and treatment of cardiac tissue rejection
09/12/2003WO2002099076A3 Sugar and lipid metabolism regulators in plants ii
09/12/2003WO2002097132A3 Nucleic acid detection method
09/12/2003WO2002088314A3 Ovary-specific genes and proteins
09/12/2003WO2002086073A3 Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
09/12/2003WO2002086066A3 Novel expansin polynucleotides, related polypeptides and methods of use
09/12/2003WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/12/2003WO2002079414A3 Transgenic mice containing clcn7 chloride channel gene disruptions
09/12/2003WO2002079224A3 Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof
09/12/2003WO2002075507A3 Anti-bacterial vaccine compositions
09/12/2003WO2002074960A3 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002072772A3 Methods and compositions for amplification of rna sequences
09/12/2003WO2002070736A3 Method for the detection of nucleic acid molecules
09/12/2003WO2002068682A3 Method for identifying biologically active structures of microbial pathogens
09/12/2003WO2002066071A3 Treatment of tissue fibrosis by blocking the sp1 transcription factor
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002061071A3 Focused libraries of genetic packages
09/12/2003WO2002059284A3 33217, a human amp-binding enzyme family member and uses thereof
09/12/2003WO2002059263A9 Transgenic animals comprising a humanized immune system
09/12/2003WO2002058727A3 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
09/12/2003WO2002057311A9 Sphingosine 1-phosphate receptor gene, sppr
09/12/2003WO2002053739A8 Neuropilin homolog zcub5
09/12/2003WO2002052011A3 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002048343A3 Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions
09/12/2003WO2002046468A3 Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides
09/12/2003WO2002046464A3 Ligand detection method
09/12/2003WO2002046391A3 Transgenic mice containing nori gene disruptions
09/12/2003WO2002044420A3 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
09/12/2003WO2002044390A3 Floral development genes
09/12/2003WO2002042461A3 Endogenous and non-endogenous versions of human g protein-coupled receptors
09/12/2003WO2002040658A3 Isomerases
09/12/2003WO2002040504A8 Sol-fusin: use of gp64-6his to catalyze membrane fusion
09/12/2003WO2002040059A3 Methods and compositions for inducing cell-mediated immune responses
09/12/2003WO2002038045A8 Techniques for deriving tissue structure from multiple projection dual-energy x-ray absorptiometry
09/12/2003WO2002036616A3 Compositions and methods relating to breast specific genes and proteins
09/12/2003WO2002033059A9 Gnk interacting amino acid decarboxylase and methods of use thereof
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002031191A3 Dendritically amplified detection method
09/12/2003WO2002030256A9 Diagnostic indicator of thymic function
09/12/2003WO2002018572A3 Membrane penetrating peptides and uses thereof
09/12/2003WO2002010454A3 Haplotypes of the alas2 gene
09/12/2003WO2002010401A9 18431 and 32374, human protein kinase family members and uses therefor
09/12/2003WO2002010390A9 57250, a human sugar transporter family member and uses thereof
09/12/2003WO2002010355A3 Alpha-amylase mutants with altered stability
09/12/2003WO2002004956A3 Method of identifying conformation-sensitive binding peptides and uses thereof
09/12/2003WO2001090197A9 Synthetic peptides and uses therefore
09/12/2003WO2001083800A9 Heterologous production of polyketides
09/12/2003WO2001071031A3 Carrier for gene detection and its use for detecting validity of interferon therapy
09/12/2003WO2000065421A3 Receptor selectivity mapping
09/12/2003CA2818688A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2754415A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2754186A1 Labeling reagents and labeled targets, target labeling processes and other processes or using same in nucleic acid determinations and anaylses
09/12/2003CA2754185A1 Labeling reagents and labeled targets, target labeling processes and other processes or using same in nucleic acid determinations and analyses
09/12/2003CA2754041A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2753922A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2753910A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2674835A1 Real-time nucleic acid detection processes and compositions
09/12/2003CA2478722A1 Methods for detecting genome-wide sequence variations associated with a phenotype
09/12/2003CA2478649A1 Means and methods for manipulating hypersensitivity-like responses
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2478493A1 Method and device for determination of tissue specificity of free floating dna in bodily fluids
09/12/2003CA2478491A1 Dna nanocage by self-organization of dna and process for producing the same, and dna nanotube and molecule carrier using the same
09/12/2003CA2478277A1 Expec-specific proteins, genes encoding them and uses thereof
09/12/2003CA2478266A1 Amino acid-producing bacteria and a process for preparing l-amino acids
09/12/2003CA2478205A1 Process for producing physiologically active protein using genetically modified silkworm
09/12/2003CA2478171A1 Apoptogenic-bacteriocins combining broad spectrum antibiotic and selective anti-tumoral activities, and compositions and uses thereof
09/12/2003CA2478015A1 Dna and vector for regulating the expression of lachrymator synthase gene, method of regulating the expression of lachrymator synthase gene using the same, and plant with the regulated expression of lachrymator synthase gene
09/12/2003CA2478014A1 Protein or polypeptide having lachrymator synthase activity, dna encoding the protein or the polypeptide, process for producing protein or polypeptide having lachrymator synthase activity using the dna, and nucleic acid molecule inhibiting the translation of mrna concerning the protein or the peptide
09/12/2003CA2477974A1 Novel compositions and methods for cancer
09/12/2003CA2477953A1 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
09/12/2003CA2477947A1 Modular recombinatorial display libraries
09/12/2003CA2477940A1 Methods of constructing a model of cellular development and differentiation using homozygous stem cell systems, methods of assessing and cataloging proteins expressed therein, cdna libraries generated therefrom, and materials and methods using same
09/12/2003CA2477876A1 Recombinant protein c variants
09/12/2003CA2477874A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003CA2477858A1 Process for the production of unsaturated fatty acids
09/12/2003CA2477856A1 Cold shock inducible expression and production of heterologous polypeptides
09/12/2003CA2477849A1 Method for producing riboflavin
09/12/2003CA2477794A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2477762A1 Peptides for use in antitumor immunotherapy
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477647A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
09/12/2003CA2477596A1 Treatment of staphylococcus infections
09/12/2003CA2477442A1 Lis promoter for expression of transgenes in floral tissues
09/12/2003CA2477411A1 Local production and/or delivery of anti-cancer agents by stromal cell precursors
09/12/2003CA2477406A1 Dna vaccine against proliferating endothelial cells and methods of use thereof
09/12/2003CA2477400A1 Treatment for asthma or allergies
09/12/2003CA2477119A1 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003CA2476724A1 Prevention of recurrence and metastasis of cancer
09/12/2003CA2476559A1 Regulated vectors for controlling dna hypermutability in eukariotic cells
09/12/2003CA2476410A1 Methods to increase or decrease bone density
09/12/2003CA2476048A1 Use of early light-inducible proteins (elip) to increase plant resistance to photochemical oxidant stress
09/12/2003CA2475690A1 Diagnostic method for glaucoma
09/12/2003CA2475572A1 Polynucleotides encoding a beta-glucosidase and uses thereof
09/12/2003CA2475370A1 Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof
09/12/2003CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003CA2421556A1 Real-time nucleic acid detection processes and compositions
09/11/2003WO2003073995A2 Dna vaccine against proliferating endothelial cells and methods of use thereof.
1 ... 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 ... 4023